Literature DB >> 11601130

Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations.

Z K Arbiser1, A L Folpe, S W Weiss.   

Abstract

We reviewed 500 consecutive soft tissue lesions referred for expert consultation to determine types of lesions and/or situations in which major discrepancies occur. Of 266 cases (53.2%) accompanied by a diagnosis, essential agreement with the second opinion was noted in 68%, minor discrepancy in 7%, and major discrepancy in 25%. The 65 major discrepancies were distributed proportionally to the referring sources and could be divided into 4 groups: benign mesenchymal lesions diagnosed as sarcomas (45%), sarcomas diagnosed as benign tumors (23%), nonmesenchymal lesions diagnosed as sarcoma (20%), and major grading discrepancies (12%). Relatively few lesions accounted for a major proportion of major discrepancies. Problematic lesions were lipoma and fasciitis and their variants and desmoplastic-neurotropic melanoma. Needle biopsy specimens were somewhat more likely to be associated with a discrepant opinion. With the exception of nonmesenchymal lesions, the diagnosis for all major discrepant cases could be made on the basis of the H&E-stained slides, suggesting that failure to perform immunostains did not account for discrepancies. Lack of familiarity with rare or unusual lesions is probably more significant in explaining diagnostic discrepancies than is the increasing use of needle biopsy or the failure to perform immunohistochemical analysis.

Entities:  

Mesh:

Year:  2001        PMID: 11601130     DOI: 10.1309/425H-NW4W-XC9A-005H

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  25 in total

1.  An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter?

Authors:  Sarah B Fisher; Yi-Ju Chiang; Barry W Feig; Janice N Cormier; Kelly K Hunt; Keila E Torres; Christina L Roland
Journal:  Am J Clin Oncol       Date:  2019-02       Impact factor: 2.339

2.  Limb salvage in malignant tumors.

Authors:  Hans-Ulrich Steinau; Adrien Daigeler; Stefan Langer; Lars Steinsträsser; Jörg Hauser; Ole Goertz; Markus Lehnhardt
Journal:  Semin Plast Surg       Date:  2010-02       Impact factor: 2.314

3.  Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo.

Authors:  David E Joyner; Mark L Wade; Aniko Szabo; Jeffrey Bastar; Cheryl M Coffin; Karen H Albritton; Philip S Bernard; R Lor Randall
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-22       Impact factor: 4.553

4.  USP6 activation in nodular fasciitis by promoter-swapping gene fusions.

Authors:  Nimesh R Patel; John S A Chrisinger; Elizabeth G Demicco; Stephen F Sarabia; Jacquelyn Reuther; Erica Kumar; Andre M Oliveira; Steven D Billings; Judith V M G Bovée; Angshumoy Roy; Alexander J Lazar; Dolores H Lopez-Terrada; Wei-Lien Wang
Journal:  Mod Pathol       Date:  2017-07-28       Impact factor: 7.842

5.  [Soft tissue sarcoma. Resection and plastic reconstruction].

Authors:  H U Steinau; L Steinsträsser; J Hauser; D Tilkorn; I Stricker; A Daigeler
Journal:  Orthopade       Date:  2012-02       Impact factor: 1.087

6.  Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems for Soft Tissue Sarcoma of the Trunk and Extremities.

Authors:  Sarah B Fisher; Yi-Ju Chiang; Barry W Feig; Janice N Cormier; Kelly K Hunt; Keila E Torres; Christina L Roland
Journal:  Ann Surg Oncol       Date:  2018-02-21       Impact factor: 5.344

Review 7.  The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.

Authors:  Roman Groisberg; Jason Roszik; Anthony Conley; Shreyaskumar R Patel; Vivek Subbiah
Journal:  Curr Oncol Rep       Date:  2017-10-13       Impact factor: 5.075

8.  A European project on incidence, treatment, and outcome of sarcoma.

Authors:  Giuseppe Mastrangelo; Emanuela Fadda; Luca Cegolon; Maria C Montesco; Isabel Ray-Coquard; Alessandra Buja; Ugo Fedeli; Alvise Frasson; Paolo Spolaore; Carlo R Rossi
Journal:  BMC Public Health       Date:  2010-04-12       Impact factor: 3.295

9.  Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.

Authors:  Antoine Lurkin; Francoise Ducimetière; Dominique Ranchère Vince; Anne-Valérie Decouvelaere; Dominic Cellier; François N Gilly; Dimitri Salameire; Pierre Biron; Guy de Laroche; Jean Yves Blay; Isabelle Ray-Coquard
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

10.  [Importance of specialized centers in diagnosis and treatment of extremity-soft tissue sarcomas. Review of 603 cases].

Authors:  M Lehnhardt; A Daigeler; H H Homann; J Hauser; S Langer; L Steinsträsser; C Soimaru; A Puls; H U Steinau
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.